Genome Biology's first Impact Fa...( Genome Biology's first Impact Factor of...)

Genome Biology is BioMed Central's flagship title covering biology in the post-genomic era. Genome Biology publishes articles from the full spectrum of biology and makes all research articles available free of charge on the website. Launched in 2001 and among the first open access journals to be published by BioMed Central, Genome Biology was also the first journal that from its inception placed all research articles in full in PubMed Central immediately on publication.

Dr Theodora Bloom, Editorial Director for Biology at BioMed Central and the founding editor of Genome Biology, is delighted, "Genome Biology was a real trailblazer in the development of open access journals and it was important that we demonstrate high editorial standards and an ability to attract the best research. Genome Biology quickly established a reputation for quality that has been affirmed by the 2005 Impact Factor. The whole team are thrilled and looking forward to seeing more exceptional research submitted to the journal."

BioMed Central's Publisher, Dr Matthew Cockerill, agrees, "Genome Biology's impressive Impact Factor is evidence of BioMed Central's commitment to quality, and shows that top researchers at the cutting edge of biology are increasingly choosing open access publication for their best work."

To date, Genome Biology has published over 2,900 articles, including important papers from the labs of many top names in the field including Mark Gerstein, Eugene Koonin, John Quackenbush, Gerry Rubin and Chris Sander. Professor Mark Gerstein of Yale University (USA), who has published five research articles in the journal, one of which has already b
'"/>

Contact: Grace Baynes
press@biomedcentral.com
44-207-631-9988
BioMed Central
20-Jun-2006